Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys.

To understand how the carbohydrate moieties of a recombinant glycoprotein affected its pharmacokinetic (PK) properties, the glycan distribution was directly assessed from serial blood samples taken during PK studies in cynomolgus monkeys and humans. The protein studied was an immunoadhesin (lenercept), containing an Fc domain from human immunoglobulin G (IgG-1) and two copies of the extensively glycosylated extra cellular domain of tumor necrosis factor receptor p55. The protein was recovered in pure form using a dual column, immunoaffinity-reversed-phase high-performance liquid chromatography method. The glycans were released and analyzed by matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS). Alternatively, trypsin was used to obtain glycopeptides, and these were analyzed by MALDI-TOF. The composition versus time profiles show that the distribution of glycans in the Fc domain was not altered over 10 days of circulation, consistent with their sequestration in the interior of the protein. However, the glycan composition in the receptor domain was changed dramatically in the first 24 h and then remained relatively constant. Analysis of the acidic glycans (derived exclusively from the receptor domain) showed that, in the rapid initial phase of clearance, glycans carrying terminal N-acetylglucosamine (tGlcNAc) were selectively cleared from the circulation. This phenomenon occurred similarly in humans and cynomolgus monkeys. Sialic acid content and terminal galactose showed only small changes. These data confirm the correlation of tGlcNAc and half-life of the molecule, and support the hypothesis that the mannose receptor (which can also bind tGlcNAc) causes the variable clearance of this molecule.

[1]  K. Anumula.  Rapid quantitative determination of sialic acids in glycoproteins by high-performance liquid chromatography with a sensitive fluorescence detection. , 1995, Analytical biochemistry.

[2]  F. Maris,et al.  Prediction of the in vivo biological activity of human recombinant follicle stimulating hormone using quantitative isoelectric focusing. , 1997, Biologicals : journal of the International Association of Biological Standardization.

[3]  A. Morell,et al.  The existence of a second route for the transfer of certain glycoproteins from the circulation into the liver. , 1976, Biochemical and biophysical research communications.

[4]  I. Sternlieb,et al.  Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. , 1968, The Journal of biological chemistry.

[5]  Stacey Ma,et al.  Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine content. , 2008, Biologicals : journal of the International Association of Biological Standardization.

[6]  N. Jenkins.  Role of physiology in the determination of protein heterogeneity. , 1996, Current opinion in biotechnology.

[7]  M. Rogge,et al.  Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers. , 1995, Therapeutic immunology.

[8]  A. Jones,et al.  Analysis of acidic oligosaccharides and glycopeptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 1996, Analytical chemistry.

[9]  W. Sly,et al.  Inhibition of the rat clearance system for agalacto-orosomucoid by yeast mannans and by mannose. , 1977, Biochemical and biophysical research communications.

[10]  Jin‐Kyoo Kim,et al.  Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site‐directed mutagenesis , 1994, European journal of immunology.

[11]  P. Bjorkman,et al.  Fc receptors and their interactions with immunoglobulins. , 1996, Annual review of cell and developmental biology.

[12]  A. Jones,et al.  Purification and quantitation of tumor necrosis factor receptor immunoadhesin using a combination of immunoaffinity and reversed-phase chromatography. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[13]  G. Gregoriadis,et al.  The role of sialic acid in determining the survival of glycoproteins in the circulation. , 1971, The Journal of biological chemistry.

[14]  Gerard E. Dallal,et al.  PC-SIZE: A Program for Sample-Size Determinations , 1986 .

[15]  K. Drickamer.  Clearing up glycoprotein hormones , 1991, Cell.

[16]  Nathan Sharon,et al.  Carbohydrates and glycoconjugates: progress in non-mammalian glycosylation, glycosyltransferases, invertebrate lectins and carbohydrate-carbohydrate interactions. , 2004, Current opinion in structural biology.

[17]  S. Wilson,et al.  Carbohydrate structures of human tissue plasminogen activator expressed in Chinese hamster ovary cells. , 1989, The Journal of biological chemistry.

[18]  G. Ashwell,et al.  Carbohydrate-specific receptors of the liver. , 1982, Annual review of biochemistry.

[19]  R. Stockert,et al.  The asialoglycoprotein receptor: relationships between structure, function, and expression. , 1995, Physiological reviews.

[20]  W. Richter,et al.  Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humans. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[21]  D A Cumming,et al.  Glycosylation of recombinant protein therapeutics: control and functional implications. , 1991, Glycobiology.

[22]  P. Capek,et al.  Ligand recognition by purified human mannose receptor. , 1992, Archives of biochemistry and biophysics.

[23]  J. Briggs,et al.  A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. , 1998, Glycobiology.

[24]  A. Morell,et al.  The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. , 2006, Advances in enzymology and related areas of molecular biology.

[25]  D. Goeddel,et al.  Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Strecker,et al.  Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin , 1975, FEBS letters.

[27]  Lihua Huang,et al.  Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization. , 2006, Analytical biochemistry.

[28]  S. Reuveny,et al.  Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation. , 1995, The Biochemical journal.

[29]  P. Stahl.  The mannose receptor and other macrophage lectins. , 1992 .

[30]  P. Stahl,et al.  The mannose receptor is a pattern recognition receptor involved in host defense. , 1998, Current opinion in immunology.

[31]  P. Umaña,et al.  The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. , 2006, The Journal of biological chemistry.

[32]  A. Ashkenazi,et al.  Immunoadhesins: principles and applications. , 1996, Trends in biotechnology.

[33]  H. Bruining,et al.  p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock: A Randomized Controlled Multicenter Trial , 1997 .

[34]  S L Morrison,et al.  Effect of glycosylation on antibody function: implications for genetic engineering. , 1997, Trends in biotechnology.

[35]  Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates and glycoconjugates , 2003 .

[36]  A. Morell,et al.  Physical and chemical studies on ceruloplasmin. IX. The role of galactosyl residues in the clearance of ceruloplasmin from the circulation. , 1970, The Journal of biological chemistry.

[37]  Mark J. Miller,et al.  Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S L Morrison,et al.  Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1 , 1994, The Journal of experimental medicine.

[39]  K. Rice,et al.  Oligosaccharide valency and conformation in determining binding to the asialoglycoprotein receptor of rat hepatocytes. , 1993, Advances in enzymology and related areas of molecular biology.

[40]  D. Banner,et al.  Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.